Volcano Targets New Markets In Therapy Guidance Products
This article was originally published in The Gray Sheet
Volcano says it wants to bolster its role as a therapy guidance company, rather than simply an intravascular diagnostics firm.
You may also be interested in...
One bright spot emerging in this otherwise lackluster economy is the market for optical imaging technologies. Optical imaging encompasses a wide array of current and emerging techniques that use light as the primary imaging modality to characterize local anatomy down to cellular and molecular levels.
Volcano’s sales of intravascular ultrasound and functional measurement disposables drove a 14% advance in the company’s fourth-quarter revenue to $81.2 million, the firm reported Feb. 23.
The company believes the Phase III Clarity AD results offer a high level of evidence that may convince the Centers for Medicare and Medicaid Services to change its stance on anti-amyloid antibodies for lecanemab.